ReproCell Poised to Jump Fivefold From IPO After Debut

ReproCell Inc., a stem-cell medical research company, is heading for the biggest opening jump for a Japanese initial public offering in nine years.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.